$ENTA SEC Filings

Filed On	Filing
27 Oct 2026	SCHEDULE 13G
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
10 Aug 2026	Form 4: Rottinghaus Scott T., Chief Medical Officer Gave up 1,467 shares to cover exercise price or tax ($19.6K)
02 Jul 2026	424B5
02 Jul 2026	8-K: Entry into a Material Definitive Agreement
23 Jun 2026	8-K: Other Events
18 Jun 2026	8-K: Regulation FD Disclosure
13 May 2026	S-8
13 May 2026	10-Q
11 May 2026	8-K: Results of Operations and Financial Condition
26 Mar 2026	SCHEDULE 13G/A
26 Mar 2026	8-K: Other Events
13 Mar 2026	Form 4: Vance Terry, Director Granted 20,000 Stock Option (right to buy)
13 Mar 2026	Form 4: Russell Lesley, Director Granted 20,000 Stock Option (right to buy)
13 Mar 2026	Form 4: Peterson Kristine, Director Granted 20,000 Stock Option (right to buy)
13 Mar 2026	Form 4: Hata Yujiro S, Director Granted 20,000 Stock Option (right to buy)
13 Mar 2026	Form 4: Foletta Mark G, Director Granted 20,000 Stock Option (right to buy)

Comments